Which has higher earnings & valuation, GMED or DXCM?

DexCom has higher revenue and earnings than Globus Medical. Globus Medical is trading at a lower price-to-earnings ratio than DexCom, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Globus Medical $2.94B 3.35 $537.87M $3.91 18.76 DexCom $4.66B 6.83 $836.30M $2.53 33.36

Is GMED or DXCM more profitable?

DexCom has a net margin of 20.12% compared to Globus Medical's net margin of 17.02%. DexCom's return on equity of 35.94% beat Globus Medical's return on equity. Company Net Margins Return on Equity Return on Assets Globus Medical 17.02% 14.57% 12.62% DexCom 20.12% 35.94% 14.75%

Does the media refer more to GMED or DXCM?

In the previous week, DexCom had 6 more articles in the media than Globus Medical. MarketBeat recorded 11 mentions for DexCom and 5 mentions for Globus Medical. DexCom's average media sentiment score of 1.06 beat Globus Medical's score of 0.28 indicating that DexCom is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Globus Medical 2 Very Positive mention(s) 2 Positive mention(s) 0 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Neutral DexCom 5 Very Positive mention(s) 1 Positive mention(s) 3 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive

Which has preferable valuation and earnings, RMD or GMED?

ResMed has higher revenue and earnings than Globus Medical. Globus Medical is trading at a lower price-to-earnings ratio than ResMed, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio ResMed $5.65B 5.64 $1.52B $10.43 21.72 Globus Medical $2.94B 3.35 $537.87M $3.91 18.76

Is RMD or GMED more profitable?

ResMed has a net margin of 26.94% compared to Globus Medical's net margin of 17.02%. ResMed's return on equity of 25.58% beat Globus Medical's return on equity. Company Net Margins Return on Equity Return on Assets ResMed 26.94% 25.58% 18.89% Globus Medical 17.02% 14.57% 12.62%

Does the media favor RMD or GMED?

In the previous week, ResMed had 1 more articles in the media than Globus Medical. MarketBeat recorded 6 mentions for ResMed and 5 mentions for Globus Medical. ResMed's average media sentiment score of 0.65 beat Globus Medical's score of 0.28 indicating that ResMed is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment ResMed 3 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Globus Medical 2 Very Positive mention(s) 2 Positive mention(s) 0 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Neutral

Does the media refer more to GMED or GEHC?

In the previous week, GE HealthCare Technologies had 21 more articles in the media than Globus Medical. MarketBeat recorded 26 mentions for GE HealthCare Technologies and 5 mentions for Globus Medical. GE HealthCare Technologies' average media sentiment score of 0.29 beat Globus Medical's score of 0.28 indicating that GE HealthCare Technologies is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Globus Medical 2 Very Positive mention(s) 2 Positive mention(s) 0 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Neutral GE HealthCare Technologies 3 Very Positive mention(s) 4 Positive mention(s) 15 Neutral mention(s) 2 Negative mention(s) 0 Very Negative mention(s) Neutral

Do analysts rate GMED or PHG?

Globus Medical currently has a consensus target price of $99.46, suggesting a potential upside of 35.58%. Given Globus Medical's stronger consensus rating and higher possible upside, analysts clearly believe Globus Medical is more favorable than Koninklijke Philips. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Globus Medical 0 Sell rating(s) 5 Hold rating(s) 9 Buy rating(s) 3 Strong Buy rating(s) 2.88 Koninklijke Philips 0 Sell rating(s) 5 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00

Does the media favor GMED or PHG?

In the previous week, Globus Medical had 3 more articles in the media than Koninklijke Philips. MarketBeat recorded 5 mentions for Globus Medical and 2 mentions for Koninklijke Philips. Globus Medical's average media sentiment score of 0.28 beat Koninklijke Philips' score of -0.42 indicating that Globus Medical is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Globus Medical 2 Very Positive mention(s) 2 Positive mention(s) 0 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Neutral Koninklijke Philips 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Neutral

Which has higher valuation & earnings, STE or GMED?

STERIS has higher revenue and earnings than Globus Medical. Globus Medical is trading at a lower price-to-earnings ratio than STERIS, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio STERIS $5.94B 3.46 $782.30M $8.18 25.75 Globus Medical $2.94B 3.35 $537.87M $3.91 18.76

Is STE or GMED more profitable?

Globus Medical has a net margin of 17.02% compared to STERIS's net margin of 13.34%. Globus Medical's return on equity of 14.57% beat STERIS's return on equity. Company Net Margins Return on Equity Return on Assets STERIS 13.34% 14.34% 9.66% Globus Medical 17.02% 14.57% 12.62%

Does the media favor STE or GMED?

In the previous week, Globus Medical had 3 more articles in the media than STERIS. MarketBeat recorded 5 mentions for Globus Medical and 2 mentions for STERIS. STERIS's average media sentiment score of 0.45 beat Globus Medical's score of 0.28 indicating that STERIS is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment STERIS 0 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Globus Medical 2 Very Positive mention(s) 2 Positive mention(s) 0 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Neutral

Globus Medical (GMED) Competitors

$74.96 +1.63 (+2.23%)

As of 02:01 PM Eastern

Compare

GMED vs. DXCM, RMD, GEHC, PHG, and STE

Should you buy Globus Medical stock or one of its competitors? Globus Medical's main competitors and comparable companies include DexCom (DXCM), ResMed (RMD), GE HealthCare Technologies (GEHC), Koninklijke Philips (PHG), and STERIS (STE). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "healthcare equipment" industry.

How does Globus Medical compare to DexCom?

Globus Medical (NYSE:GMED) and DexCom (NASDAQ:DXCM) are both healthcare companies, but which is the superior investment? We will contrast the two companies based on the strength of their earnings, dividends, valuation, profitability, risk, analyst recommendations, media sentiment and institutional ownership.

Globus Medical currently has a consensus target price of $99.46, suggesting a potential upside of 35.58%. DexCom has a consensus target price of $91.96, suggesting a potential upside of 8.94%. Given Globus Medical's higher possible upside, equities research analysts plainly believe Globus Medical is more favorable than DexCom.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Globus Medical	0 Sell rating(s)	5 Hold rating(s)	9 Buy rating(s)	3 Strong Buy rating(s)	2.88
DexCom	0 Sell rating(s)	2 Hold rating(s)	19 Buy rating(s)	3 Strong Buy rating(s)	3.04

Globus Medical has a beta of 0.96, suggesting that its share price is 4% less volatile than the broader market. Comparatively, DexCom has a beta of 1.48, suggesting that its share price is 48% more volatile than the broader market.

DexCom has higher revenue and earnings than Globus Medical. Globus Medical is trading at a lower price-to-earnings ratio than DexCom, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Globus Medical	$2.94B	3.35	$537.87M	$3.91	18.76
DexCom	$4.66B	6.83	$836.30M	$2.53	33.36

DexCom has a net margin of 20.12% compared to Globus Medical's net margin of 17.02%. DexCom's return on equity of 35.94% beat Globus Medical's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Globus Medical	17.02%	14.57%	12.62%
DexCom	20.12%	35.94%	14.75%

95.2% of Globus Medical shares are held by institutional investors. Comparatively, 97.8% of DexCom shares are held by institutional investors. 18.4% of Globus Medical shares are held by insiders. Comparatively, 0.3% of DexCom shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

In the previous week, DexCom had 6 more articles in the media than Globus Medical. MarketBeat recorded 11 mentions for DexCom and 5 mentions for Globus Medical. DexCom's average media sentiment score of 1.06 beat Globus Medical's score of 0.28 indicating that DexCom is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Globus Medical	2 Very Positive mention(s)	2 Positive mention(s)	0 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Neutral
DexCom	5 Very Positive mention(s)	1 Positive mention(s)	3 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive

Summary

DexCom beats Globus Medical on 13 of the 16 factors compared between the two stocks.

How does Globus Medical compare to ResMed?

ResMed (NYSE:RMD) and Globus Medical (NYSE:GMED) are both healthcare companies, but which is the better stock? We will contrast the two businesses based on the strength of their dividends, media sentiment, valuation, risk, earnings, profitability, institutional ownership and analyst recommendations.

ResMed presently has a consensus target price of $241.69, indicating a potential upside of 6.70%. Globus Medical has a consensus target price of $99.46, indicating a potential upside of 35.58%. Given Globus Medical's stronger consensus rating and higher probable upside, analysts plainly believe Globus Medical is more favorable than ResMed.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
ResMed	0 Sell rating(s)	9 Hold rating(s)	7 Buy rating(s)	0 Strong Buy rating(s)	2.44
Globus Medical	0 Sell rating(s)	5 Hold rating(s)	9 Buy rating(s)	3 Strong Buy rating(s)	2.88

ResMed has a beta of 0.75, suggesting that its stock price is 25% less volatile than the broader market. Comparatively, Globus Medical has a beta of 0.96, suggesting that its stock price is 4% less volatile than the broader market.

55.0% of ResMed shares are owned by institutional investors. Comparatively, 95.2% of Globus Medical shares are owned by institutional investors. 0.6% of ResMed shares are owned by company insiders. Comparatively, 18.4% of Globus Medical shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

ResMed has higher revenue and earnings than Globus Medical. Globus Medical is trading at a lower price-to-earnings ratio than ResMed, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
ResMed	$5.65B	5.64	$1.52B	$10.43	21.72
Globus Medical	$2.94B	3.35	$537.87M	$3.91	18.76

ResMed has a net margin of 26.94% compared to Globus Medical's net margin of 17.02%. ResMed's return on equity of 25.58% beat Globus Medical's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
ResMed	26.94%	25.58%	18.89%
Globus Medical	17.02%	14.57%	12.62%

In the previous week, ResMed had 1 more articles in the media than Globus Medical. MarketBeat recorded 6 mentions for ResMed and 5 mentions for Globus Medical. ResMed's average media sentiment score of 0.65 beat Globus Medical's score of 0.28 indicating that ResMed is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
ResMed	3 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Globus Medical	2 Very Positive mention(s)	2 Positive mention(s)	0 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Neutral

Summary

ResMed beats Globus Medical on 10 of the 17 factors compared between the two stocks.

How does Globus Medical compare to GE HealthCare Technologies?

Globus Medical (NYSE:GMED) and GE HealthCare Technologies (NASDAQ:GEHC) are both healthcare companies, but which is the better investment? We will compare the two businesses based on the strength of their dividends, valuation, institutional ownership, earnings, analyst recommendations, risk, media sentiment and profitability.

In the previous week, GE HealthCare Technologies had 21 more articles in the media than Globus Medical. MarketBeat recorded 26 mentions for GE HealthCare Technologies and 5 mentions for Globus Medical. GE HealthCare Technologies' average media sentiment score of 0.29 beat Globus Medical's score of 0.28 indicating that GE HealthCare Technologies is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Globus Medical	2 Very Positive mention(s)	2 Positive mention(s)	0 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Neutral
GE HealthCare Technologies	3 Very Positive mention(s)	4 Positive mention(s)	15 Neutral mention(s)	2 Negative mention(s)	0 Very Negative mention(s)	Neutral

Globus Medical has a net margin of 17.02% compared to GE HealthCare Technologies' net margin of 9.33%. GE HealthCare Technologies' return on equity of 20.12% beat Globus Medical's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Globus Medical	17.02%	14.57%	12.62%
GE HealthCare Technologies	9.33%	20.12%	5.74%

95.2% of Globus Medical shares are owned by institutional investors. Comparatively, 82.1% of GE HealthCare Technologies shares are owned by institutional investors. 18.4% of Globus Medical shares are owned by insiders. Comparatively, 0.4% of GE HealthCare Technologies shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

GE HealthCare Technologies has higher revenue and earnings than Globus Medical. GE HealthCare Technologies is trading at a lower price-to-earnings ratio than Globus Medical, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Globus Medical	$2.94B	3.35	$537.87M	$3.91	18.76
GE HealthCare Technologies	$20.63B	1.41	$2.08B	$4.36	14.73

Globus Medical has a beta of 0.96, suggesting that its share price is 4% less volatile than the broader market. Comparatively, GE HealthCare Technologies has a beta of 0.73, suggesting that its share price is 27% less volatile than the broader market.

Globus Medical presently has a consensus target price of $99.46, suggesting a potential upside of 35.58%. GE HealthCare Technologies has a consensus target price of $78.52, suggesting a potential upside of 22.27%. Given Globus Medical's stronger consensus rating and higher probable upside, analysts clearly believe Globus Medical is more favorable than GE HealthCare Technologies.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Globus Medical	0 Sell rating(s)	5 Hold rating(s)	9 Buy rating(s)	3 Strong Buy rating(s)	2.88
GE HealthCare Technologies	0 Sell rating(s)	10 Hold rating(s)	11 Buy rating(s)	1 Strong Buy rating(s)	2.59

Summary

Globus Medical beats GE HealthCare Technologies on 10 of the 17 factors compared between the two stocks.

How does Globus Medical compare to Koninklijke Philips?

Globus Medical (NYSE:GMED) and Koninklijke Philips (NYSE:PHG) are both healthcare companies, but which is the superior investment? We will compare the two businesses based on the strength of their dividends, valuation, media sentiment, earnings, analyst recommendations, institutional ownership, profitability and risk.

Globus Medical currently has a consensus target price of $99.46, suggesting a potential upside of 35.58%. Given Globus Medical's stronger consensus rating and higher possible upside, analysts clearly believe Globus Medical is more favorable than Koninklijke Philips.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Globus Medical	0 Sell rating(s)	5 Hold rating(s)	9 Buy rating(s)	3 Strong Buy rating(s)	2.88
Koninklijke Philips	0 Sell rating(s)	5 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	2.00

95.2% of Globus Medical shares are owned by institutional investors. Comparatively, 13.7% of Koninklijke Philips shares are owned by institutional investors. 18.4% of Globus Medical shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.

Globus Medical has a beta of 0.96, meaning that its share price is 4% less volatile than the broader market. Comparatively, Koninklijke Philips has a beta of 0.77, meaning that its share price is 23% less volatile than the broader market.

Koninklijke Philips has higher revenue and earnings than Globus Medical. Koninklijke Philips is trading at a lower price-to-earnings ratio than Globus Medical, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Globus Medical	$2.94B	3.35	$537.87M	$3.91	18.76
Koninklijke Philips	$20.17B	1.18	$1.01B	$1.36	17.86

In the previous week, Globus Medical had 3 more articles in the media than Koninklijke Philips. MarketBeat recorded 5 mentions for Globus Medical and 2 mentions for Koninklijke Philips. Globus Medical's average media sentiment score of 0.28 beat Koninklijke Philips' score of -0.42 indicating that Globus Medical is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Globus Medical	2 Very Positive mention(s)	2 Positive mention(s)	0 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Neutral
Koninklijke Philips	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Neutral

Globus Medical has a net margin of 17.02% compared to Koninklijke Philips' net margin of 6.30%. Globus Medical's return on equity of 14.57% beat Koninklijke Philips' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Globus Medical	17.02%	14.57%	12.62%
Koninklijke Philips	6.30%	14.38%	5.96%

Summary

Globus Medical beats Koninklijke Philips on 15 of the 17 factors compared between the two stocks.

How does Globus Medical compare to STERIS?

STERIS (NYSE:STE) and Globus Medical (NYSE:GMED) are both healthcare companies, but which is the better business? We will contrast the two companies based on the strength of their dividends, valuation, analyst recommendations, media sentiment, institutional ownership, risk, profitability and earnings.

Globus Medical has a net margin of 17.02% compared to STERIS's net margin of 13.34%. Globus Medical's return on equity of 14.57% beat STERIS's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
STERIS	13.34%	14.34%	9.66%
Globus Medical	17.02%	14.57%	12.62%

94.7% of STERIS shares are owned by institutional investors. Comparatively, 95.2% of Globus Medical shares are owned by institutional investors. 1.1% of STERIS shares are owned by insiders. Comparatively, 18.4% of Globus Medical shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

STERIS has higher revenue and earnings than Globus Medical. Globus Medical is trading at a lower price-to-earnings ratio than STERIS, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
STERIS	$5.94B	3.46	$782.30M	$8.18	25.75
Globus Medical	$2.94B	3.35	$537.87M	$3.91	18.76

STERIS has a beta of 0.92, indicating that its stock price is 8% less volatile than the broader market. Comparatively, Globus Medical has a beta of 0.96, indicating that its stock price is 4% less volatile than the broader market.

STERIS currently has a consensus price target of $271.33, indicating a potential upside of 28.83%. Globus Medical has a consensus price target of $99.46, indicating a potential upside of 35.58%. Given Globus Medical's stronger consensus rating and higher probable upside, analysts clearly believe Globus Medical is more favorable than STERIS.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
STERIS	0 Sell rating(s)	1 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.75
Globus Medical	0 Sell rating(s)	5 Hold rating(s)	9 Buy rating(s)	3 Strong Buy rating(s)	2.88

In the previous week, Globus Medical had 3 more articles in the media than STERIS. MarketBeat recorded 5 mentions for Globus Medical and 2 mentions for STERIS. STERIS's average media sentiment score of 0.45 beat Globus Medical's score of 0.28 indicating that STERIS is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
STERIS	0 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Globus Medical	2 Very Positive mention(s)	2 Positive mention(s)	0 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Neutral

Summary

Globus Medical beats STERIS on 11 of the 17 factors compared between the two stocks.

Get Globus Medical News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding GMED and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

GMED vs. The Competition

Export

Metric	Globus Medical	Healthcare Equipment & Supplies Industry	Healthcare Sector	NYSE Exchange
Market Cap	$10.06B	$5.44B	$7.21B	$22.99B
Dividend Yield	N/A	1.78%	2.53%	3.72%
P/E Ratio	19.16	25.43	274.52	28.64
Price / Sales	3.42	70.42	585.83	23.59
Price / Cash	11.74	32.10	76.82	36.46
Price / Book	2.21	5.90	11.21	4.72
Net Income	$537.87M	$146.18M	$3.50B	$1.07B
7 Day Performance	-0.88%	-0.52%	-0.78%	0.45%
1 Month Performance	0.47%	-3.46%	-5.37%	-3.70%
1 Year Performance	25.63%	2.71%	4.65%	6.67%

Globus Medical Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
GMED Globus Medical	4.2678 of 5 stars	$74.96 +2.2%	$99.46 +32.7%	+21.3%	$10.06B	$2.94B	19.16	6,000
DXCM DexCom	4.2781 of 5 stars	$86.68 +0.1%	$89.08 +2.8%	+24.5%	$32.69B	$4.66B	34.26	11,100	Analyst Upgrade
RMD ResMed	3.5958 of 5 stars	$222.38 +0.2%	$241.69 +8.7%	-19.8%	$32.02B	$5.65B	21.32	11,370	Insider Trade
GEHC GE HealthCare Technologies	4.5329 of 5 stars	$66.78 +0.2%	$78.39 +17.4%	-14.5%	$30.10B	$20.63B	15.32	54,000	Analyst Upgrade
PHG Koninklijke Philips	2.6381 of 5 stars	$25.11 +0.6%	N/A	-14.1%	$24.53B	$20.17B	18.51	65,340	Analyst Downgrade

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NYSE:GMED) was last updated on 10/9/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Globus Medical (GMED) Competitors

GMED vs. DXCM, RMD, GEHC, PHG, and STE

How does Globus Medical compare to DexCom?

Summary

How does Globus Medical compare to ResMed?

Summary

How does Globus Medical compare to GE HealthCare Technologies?

Summary

How does Globus Medical compare to Koninklijke Philips?

Summary

How does Globus Medical compare to STERIS?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

GMED vs. The Competition

Globus Medical Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Globus Medical (GMED) Competitors

GMED vs. DXCM, RMD, GEHC, PHG, and STE

How does Globus Medical compare to DexCom?

Do analysts recommend GMED or DXCM?

Which has more risk and volatility, GMED or DXCM?

Which has higher earnings & valuation, GMED or DXCM?

Is GMED or DXCM more profitable?

Do insiders and institutionals hold more shares of GMED or DXCM?

Does the media refer more to GMED or DXCM?

Summary

How does Globus Medical compare to ResMed?

Do analysts rate RMD or GMED?

Which has more volatility & risk, RMD or GMED?

Do institutionals and insiders believe in RMD or GMED?

Which has preferable valuation and earnings, RMD or GMED?

Is RMD or GMED more profitable?

Does the media favor RMD or GMED?

Summary

How does Globus Medical compare to GE HealthCare Technologies?

Does the media refer more to GMED or GEHC?

Is GMED or GEHC more profitable?

Do institutionals & insiders have more ownership in GMED or GEHC?

Which has higher valuation & earnings, GMED or GEHC?

Which has more volatility & risk, GMED or GEHC?

Do analysts prefer GMED or GEHC?

Summary

How does Globus Medical compare to Koninklijke Philips?

Do analysts rate GMED or PHG?

Do insiders and institutionals have more ownership in GMED or PHG?

Which has more risk & volatility, GMED or PHG?

Which has higher earnings and valuation, GMED or PHG?

Does the media favor GMED or PHG?

Is GMED or PHG more profitable?

Summary

How does Globus Medical compare to STERIS?

Is STE or GMED more profitable?

Do insiders & institutionals believe in STE or GMED?

Which has higher valuation & earnings, STE or GMED?

Which has more risk & volatility, STE or GMED?

Do analysts recommend STE or GMED?

Does the media favor STE or GMED?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

GMED vs. The Competition

Globus Medical Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools